Venous Thromboembolism in DM1 (DM1-VTE)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03141749|
Recruitment Status : Completed
First Posted : May 5, 2017
Last Update Posted : May 9, 2017
|Condition or disease|
|Venous Thromboembolism Pulmonary Embolism Deep Vein Thrombosis Myopathy Myotonic Dystrophy 1|
A cohort of more that 2,800 adult patients admitted to our Institutions between January 2000 and November 2014 with genetically proven myopathy will be retrospectively included.
Any information relative to their demographic and genetic characteristics, their muscular functional status and the occurrence of VTE will be collected.
Statistical analysis will be performed to estimate the incidence of venous thromboembolism in this population, to identify predictors of VTE, and to compare its incidence to a community-based population.
|Study Type :||Observational|
|Actual Enrollment :||2810 participants|
|Official Title:||Incidence and Predictors of Venous Thromboembolism in Myotonic Dystrophy|
|Actual Study Start Date :||January 2000|
|Actual Primary Completion Date :||November 2014|
|Actual Study Completion Date :||January 2017|
- Any episode of pulmonary embolism and/or deep vein thrombosis, diagnosed according to 2011 AHA guidelines on venous thromboembolism management [ Time Frame: 14 years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03141749
|Principal Investigator:||Karim Wahbi, MD, PhD||Institut de Myologie, Paris, FRANCE|